These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1868674)

  • 1. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.
    Crom WR; Relling MV; Christensen ML; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1991 Aug; 50(2):132-40. PubMed ID: 1868674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver volume as a determinant of drug clearance in children and adolescents.
    Murry DJ; Crom WR; Reddick WE; Bhargava R; Evans WE
    Drug Metab Dispos; 1995 Oct; 23(10):1110-6. PubMed ID: 8654200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced hepatic drug clearance in patients with cystic fibrosis.
    Kearns GL; Mallory GB; Crom WR; Evans WE
    J Pediatr; 1990 Dec; 117(6):972-9. PubMed ID: 2246703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
    Relling MV; Crom WR; Pieper JA; Cupit GC; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1987 Jun; 41(6):651-60. PubMed ID: 3472701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neurotrauma on hepatic drug clearance.
    Boucher BA; Kuhl DA; Fabian TC; Robertson JT
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):487-97. PubMed ID: 1934861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine plasma and urine metabolite disposition with lorazepam coadministration.
    St Peter JV; Halstenson CE; Awni WM
    Pharmacotherapy; 1991; 11(2):171-4. PubMed ID: 2052472
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous administration of multiple model substrates to assess hepatic drug clearance.
    Crom WR; Webster SL; Bobo L; Teresi ME; Relling MV; Evans WE
    Clin Pharmacol Ther; 1987 Jun; 41(6):645-50. PubMed ID: 3581648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorazepam pharmacodynamics and pharmacokinetics in children.
    Relling MV; Mulhern RK; Dodge RK; Johnson D; Pieper JA; Rivera GK; Evans WE
    J Pediatr; 1989 Apr; 114(4 Pt 1):641-6. PubMed ID: 2926577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.
    Scavone JM; Blyden GT; Greenblatt DJ
    Clin Pharmacokinet; 1989 Mar; 16(3):180-5. PubMed ID: 2721087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.
    Greenblatt DJ; Allen MD; MacLaughlin DS; Huffman DH; Harmatz JS; Shader RI
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):159-79. PubMed ID: 20218012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
    Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB
    Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam.
    Abernethy DR; Greenblatt DJ; Eshelman FN; Shader RI
    Clin Pharmacol Ther; 1984 Feb; 35(2):188-92. PubMed ID: 6319067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic drug clearance in children: studies with indocyanine green as a model substrate.
    Evans WE; Relling MV; de Graaf S; Rodman JH; Pieper JA; Christensen ML; Crom WR
    J Pharm Sci; 1989 Jun; 78(6):452-6. PubMed ID: 2760818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
    Andersen V; Sonne J; Larsen S
    Scand J Gastroenterol; 1999 Aug; 34(8):813-7. PubMed ID: 10499483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
    Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in salivary antipyrine pharmacokinetics during adolescence, correlated with age, hormonal levels and Tanner stage.
    Linday LA; Greenblatt DJ; Warren MP; Harmatz JS; DeCresce R; Cicalese C; LeDuc BW
    Dev Pharmacol Ther; 1991; 16(4):194-202. PubMed ID: 1782837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Divoll MK; Abernethy DR; Ochs HR; Harmatz JS; Shader RI
    Pharmacology; 1989; 38(5):327-34. PubMed ID: 2762375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic cage isolation reduces antipyrine clearance in rats.
    Brunner LJ; Dipiro JT; Feldman S
    J Pharm Pharmacol; 1994 Jul; 46(7):581-4. PubMed ID: 7996387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of experimental hemorrhagic shock on hepatic drug elimination.
    DiPiro JT; Hooker KD; Sherman JC; Gaines MG; Wynn JJ
    Crit Care Med; 1992 Jun; 20(6):810-5. PubMed ID: 1597036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.